The following products with batch numbers C501591 and C501590 are affected:
|Ondansetron 4mg, 10 Tablets||DRLA||163428|
|Ondansetron 8mg, 10 Tablets||DRLA||163429|
|Ondansetron 4mg, 4 Tablets||SZ||163438|
|Ondansetron 4mg, 10 Tablets||SZ||163438|
|Ondansetron 8mg, 4 Tablets||SZ||163439|
|Ondansetron 8mg, 10 Tablets||SZ||163439|
The recall is a precautionary measure in response to detection of an impurity level out of specification early in the product’s shelf-life.
Please inspect your stocks and quarantine all products from the batches listed above for return to your supplier for a refund.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Dr Reddy’s Laboratories (Australia) on 1800 733 397.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.